These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11753085)

  • 1. Renal cancer: molecular mechanisms and newer therapeutic options.
    Karumanchi SA; Merchan J; Sukhatme VP
    Curr Opin Nephrol Hypertens; 2002 Jan; 11(1):37-42. PubMed ID: 11753085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms.
    Cheng L; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R
    Hum Pathol; 2009 Jan; 40(1):10-29. PubMed ID: 19027455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing concepts in the management of renal oncocytoma.
    Chao DH; Zisman A; Pantuck AJ; Freedland SJ; Said JW; Belldegrun AS
    Urology; 2002 May; 59(5):635-42. PubMed ID: 11992832
    [No Abstract]   [Full Text] [Related]  

  • 4. Inactivation of BHD in sporadic renal tumors.
    Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
    Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours.
    Sanjmyatav J; Hauke S; Gajda M; Hartmann A; Moch H; Meyer B; Pryalukhin A; Grimm MO; Junker K
    Eur Urol; 2013 Oct; 64(4):689-91. PubMed ID: 23790440
    [No Abstract]   [Full Text] [Related]  

  • 6. Application of molecular diagnostic techniques to renal epithelial neoplasms.
    Jones TD; Eble JN; Cheng L
    Clin Lab Med; 2005 Jun; 25(2):279-303. PubMed ID: 15848737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Jimsgene Sanjmyatav, Sven Hauke, Mieczyslaw Gajda, et al. Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours. Eur Urol 2013;64:689-91.
    Verine J; Leboeuf C; Ratajczak P
    Eur Urol; 2014 May; 65(5):e69-70. PubMed ID: 24341959
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular profiling of renal cancer: the journey to clinical application.
    Ribal MJ
    Eur Urol; 2011 May; 59(5):731-3. PubMed ID: 21296486
    [No Abstract]   [Full Text] [Related]  

  • 9. Origin of renal cell carcinomas.
    Valladares Ayerbes M; Aparicio Gallego G; Díaz Prado S; Jiménez Fonseca P; García Campelo R; Antón Aparicio LM
    Clin Transl Oncol; 2008 Nov; 10(11):697-712. PubMed ID: 19015066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving understanding and surgical management of renal cortical tumors.
    Russo P
    Mayo Clin Proc; 2000 Dec; 75(12):1233-5. PubMed ID: 11126829
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Jérôme Verine, Christophe Leboeuf and Philippe Ratajczak's letter to the editor re: Jimsgene Sanjmyatav, Sven Hauke, Mieczyslaw Gajda, et al. Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours. Eur Urol 2013;64:689-91.
    Sanjmyatav J; Hartmann A; Moch H; Hauke S; Gajda M; Meyer B; Pryalukhin A; Grimm MO; Junker K
    Eur Urol; 2014 May; 65(5):e71-2. PubMed ID: 24332347
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential role of genetic markers in the management of kidney cancer.
    Junker K; Ficarra V; Kwon ED; Leibovich BC; Thompson RH; Oosterwijk E
    Eur Urol; 2013 Feb; 63(2):333-40. PubMed ID: 23040205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular characterization and therapeutic strategies of papillary renal cell carcinoma.
    Chen Q; Cheng L; Li Q
    Expert Rev Anticancer Ther; 2019 Feb; 19(2):169-175. PubMed ID: 30474436
    [No Abstract]   [Full Text] [Related]  

  • 14. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity.
    Shuch B; Amin A; Armstrong AJ; Eble JN; Ficarra V; Lopez-Beltran A; Martignoni G; Rini BI; Kutikov A
    Eur Urol; 2015 Jan; 67(1):85-97. PubMed ID: 24857407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics and histopathologic features of adult distal nephron tumors.
    Polascik TJ; Bostwick DG; Cairns P
    Urology; 2002 Dec; 60(6):941-6. PubMed ID: 12475646
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal tumors exhibiting granular cytoplasm.
    Reuter VE
    Semin Diagn Pathol; 1999 May; 16(2):135-45. PubMed ID: 10452579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic basis of cancer of the kidney.
    Sudarshan S; Linehan WM
    Semin Oncol; 2006 Oct; 33(5):544-51. PubMed ID: 17045083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis.
    Bugert P; Kovacs G
    Am J Pathol; 1996 Dec; 149(6):2081-8. PubMed ID: 8952540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
    Brauch H; Weirich G; Brieger J; Glavac D; Rödl H; Eichinger M; Feurer M; Weidt E; Puranakanitstha C; Neuhaus C; Pomer S; Brenner W; Schirmacher P; Störkel S; Rotter M; Masera A; Gugeler N; Decker HJ
    Cancer Res; 2000 Apr; 60(7):1942-8. PubMed ID: 10766184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.